Bond Liquidity and Dealer Inventories: Insights from US and European Regulatory Data

2020 ◽  
Author(s):  
Plamen Ivanov ◽  
Alexei G. Orlov ◽  
Michael Schihl
Keyword(s):  
Regulatory Data ◽  
European Regulatory ◽  
Bond Liquidity

ECPA Crop Protection European Regulatory Conference 2018

2018 ◽  
Vol 29 (3) ◽  
pp. 141-144
Keyword(s):  
Crop Protection ◽  
European Regulatory

Corporate Yield Spreads and Bond Liquidity

CFA Digest ◽  
2007 ◽  
Vol 37 (3) ◽  
pp. 18-19
Author(s):  
Edgar J. Sullivan
Keyword(s):  
Yield Spreads ◽  
Bond Liquidity

Comparing Possible Proxies of Corporate Bond Liquidity

CFA Digest ◽  
2005 ◽  
Vol 35 (4) ◽  
pp. 29-30
Author(s):  
Joseph D.V. Vu
Keyword(s):  
Corporate Bond ◽  
Bond Liquidity

The Principle of Shareholder Primacy in Company Law from a Nordic and European Regulatory Perspective

2011 ◽  
Author(s):  
Paul Krüger Andersen ◽  
Evelyne J.B. Sørensen
Keyword(s):  
Company Law ◽  
Shareholder Primacy ◽  
Regulatory Perspective ◽  
European Regulatory

Agencies in the European Regulatory Union

2016 ◽  
Author(s):  
Herwig C.H. Hofmann
Keyword(s):  
European Regulatory

The Determinants of Dim Sum Bond Liquidity

2020 ◽  
Author(s):  
Lei Meng ◽  
Thanos Verousis ◽  
Vasiliki Delitheou
Keyword(s):  
Bond Liquidity

Bond Liquidity Premia

2009 ◽  
Author(s):  
Jean-Sebastien Fontaine ◽  
René Garcia
Keyword(s):  
Bond Liquidity ◽  
Liquidity Premia

scholarly journals Adverse Drug Reaction Reporting by Patients in 12 European Countries

2021 ◽  
Vol 18 (4) ◽  
pp. 1507
Author(s):  
Agne Valinciute-Jankauskiene ◽  
Loreta Kubiliene
Keyword(s):  
Statistical Analysis ◽  
Adverse Drug Reaction Reporting ◽  
Regulatory System ◽  
European Countries ◽  
Pharmacovigilance System ◽  
Common Source ◽  
Patient Reporting ◽  
Safety Risks ◽  
European Regulatory ◽  
National Competent Authorities

Patients who report suspected adverse drug reactions (ADRs) help minimize drug safety risks and bolster the pharmacovigilance system. The aim of this study was to examine the contribution of patients to pharmacovigilance and compare the tools used to promote patient reporting in European countries that implemented this reporting type in 2012–2013. A web-based questionnaire was sent to the national competent authorities (NCAs) of the European countries. The received answers were systematized and compared using statistical analysis. The performed statistical analysis demonstrated that changes in the number of received ADR reports increased significantly in each country during the analyzed period. These changes were significantly different in Ireland and Finland from those in the other reviewed countries. The common source of information on direct patient reporting was the country’s NCA website. Other sources used were social media pages, leaflets, and posters. This is the first study on patient reporting schemes implemented after the significant reform of the European regulatory system for pharmacovigilance. However, some countries did not actively promote their patient reporting schemes. Our findings indicate that countries with minimal experience in pharmacovigilance systems that include direct patient reporting should organize comprehensive campaigns on ADR reporting.

scholarly journals Data Dentistry: How Data Are Changing Clinical Care and Research

2021 ◽  
pp. 002203452110202
Author(s):  
F. Schwendicke ◽  
J. Krois
Keyword(s):  
Health Care ◽  
Data Sharing ◽  
Clinical Care ◽  
Open Data ◽  
User Interaction ◽  
Data Availability ◽  
Related Data ◽  
Data User ◽  
Regulatory Data ◽  
Consumer Data

Data are a key resource for modern societies and expected to improve quality, accessibility, affordability, safety, and equity of health care. Dental care and research are currently transforming into what we term data dentistry, with 3 main applications: 1) medical data analysis uses deep learning, allowing one to master unprecedented amounts of data (language, speech, imagery) and put them to productive use. 2) Data-enriched clinical care integrates data from individual (e.g., demographic, social, clinical and omics data, consumer data), setting (e.g., geospatial, environmental, provider-related data), and systems level (payer or regulatory data to characterize input, throughput, output, and outcomes of health care) to provide a comprehensive and continuous real-time assessment of biologic perturbations, individual behaviors, and context. Such care may contribute to a deeper understanding of health and disease and a more precise, personalized, predictive, and preventive care. 3) Data for research include open research data and data sharing, allowing one to appraise, benchmark, pool, replicate, and reuse data. Concerns and confidence into data-driven applications, stakeholders’ and system’s capabilities, and lack of data standardization and harmonization currently limit the development and implementation of data dentistry. Aspects of bias and data-user interaction require attention. Action items for the dental community circle around increasing data availability, refinement, and usage; demonstrating safety, value, and usefulness of applications; educating the dental workforce and consumers; providing performant and standardized infrastructure and processes; and incentivizing and adopting open data and data sharing.

Sign in / Sign up

Export Citation Format

Share Document